Navigation Links
NJIT computer scientist publishes new algorithm cluster to data mine health records
Date:5/14/2013

The time may be fast approaching for researchers to take better advantage of the vast amount of valuable patient information available from U.S. electronic health records. Lian Duan, an NJIT computer scientist with an expertise in data mining, has done just that with the recent publication of "Adverse Drug Effect Detection," IEEE Journal of Biomedical and Health Informatics (March, 2013).

The article spotlights a new and promising way of using a combination of commonly used existing algorithms to root out more information about adverse drug reactions within electronic health records available to the researchers. The new pattern, which when compared against the most commonly used existing sole algorithm, showed an almost 25 percent improvement in outcome. Although the idea could theoretically be applied beyond electronic health records, this paper focuses only on using them to find adverse medical reactions to a drug therapy.

"Large collections of electronic patient records have long provided abundant, but under-explored information on the real-world use of medicines. But when used properly these records can provide longitudinal observational data which is perfect for data mining," Duan said. "Although such records are maintained for patient administration, they could provide a broad range of clinical information for data analysis. A growing interest has been drug safety."

In this paper, the researchers proposed two novel algorithmsa likelihood ratio model and a Bayesian network modelfor adverse drug effect discovery. Although the performance of these two algorithms is comparable to the state-of-the-art algorithm, Bayesian confidence propagation neural network, by combining three works, the researchers say one can get better, more diverse results.

Since the actual adverse drug effects on a given dataset cannot be absolutely determined, the researchers made use of a simulated observational medical outcomes
'/>"/>

Contact: Sheryl Weinstein
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CipherLab Exhibits Its Latest CP60 Mobile Computers and 1600 Series Barcode Scanners for Courier Industry at MCAA’s Annual Meeting & Exposition, Booth# 10, May 8-10, 2013
2. Computer algorithms help find cancer connections
3. Are Pricey Computer-Aided Mammograms Worth It?
4. Atlanta LASIK Surgeon Interviewed About Computer Vision Syndrome Prevention
5. Watson, IBM'S Supercomputer is Now Programmed to Recommend Perispinally Administered Etanercept as an Alzheimer's Disease Treatment
6. Study: Computerized reminders significantly improve HIV care in resource-limited setting
7. Could a computer on the police beat prevent violence?
8. Can computers save health care? IU research shows lower costs, better outcomes
9. YogaDownload and YogaFit® Team Up to Bring World’s Largest Yoga Fitness School Straight to Your Computer
10. Phoenix Synergy Discusses securing computer networks at the AZPMA conference in Las Vegas
11. Mobile Computer Cart Rental Program Launched by Add-On Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... In a world enveloped in ... has lessened, and due to the intrusion of ... sleep has eroded. According to Web MD, one ... (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This remarkably high number ... incalculable amount, leading not only to dissatisfied employers, ...
(Date:11/27/2014)... 2014 An inventor from Buffalo, N.Y., ... of life, and she wants to lessen its impact. ... I decided that there needed to be a way ... Easy to use and producible in design variations, the ... private areas throughout the day. It avoids bad odors, ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Nearly ... been filed in a consolidated litigation now underway ... , Documents recently updated in the Philadelphia ... in the state proceeding, all of which involve ... and other psychiatric conditions. Many of the cases ...
(Date:11/27/2014)... -- Most babies and young children don,t need medicines ... Drug Administration says. Over-the-counter (OTC) cold and cough ... 2 because they could cause serious and potentially deadly ... about three colds a year, but children get them ... want to give them pain relievers, decongestants and other ...
(Date:11/27/2014)... meals can pose a challenge for people who have ... Many traditional Thanksgiving dishes -- such as turkey, corn, ... "when it comes to pies, stuffing, gravy, etc., gluten-free ... director of the Gluten and Allergic Digestive Disorders program ... said in a center news release. "For those ...
Breaking Medicine News(10 mins):Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:Expert Shares Gluten-Free Thanksgiving Tips 2
... ptient with a turbocharger for the heart called C-Pulse.// ... moderate heart problems, who are still not ill enough to ... These patients may be those who may feel extreme tiredness, ... help from medications. ,The new device is a balloon ...
... may have less tolerance to alcohol intakes than men, suggests ... 2005//. ,Researchers of University of Pittsburgh School of Medicine ... things to women than their male counterparts. Women may be ... men even if they have the same amount of the ...
... colonoscopy may be the favorable method to screen women// ... cancer, flexible sigmoidoscopy is used to detect colorectal neoplasias, ... dysplasia, or cancer. Researchers had used colonoscopy to detect ... women who were referred for colon-cancer screenings. ,Of the ...
... that extracts of the grapefruit seeds contain antioxidants ... a fruit, grapefruit had been associated with acidity ... and helpful ingredients that have healing properties. Researchers ... and presented their study findings at the Digestive ...
... research presented at Digestive Disease Week 2005, antidepressants ... depression, also known as unipolar depression, is often ... inhibitors (SSRIs) by physicians. , ,Previous research ... (NSAID) can cause increased bleeding and hemorrhage in ...
... Baptist Medical Center, US, have found that low doses ... and thus limits the side effects of the therapy ... chemotherapy given to children suffering from Acute Lymphblastic Leukemia ... cancer were administered very limited dosage of chemotherapy and ...
Cached Medicine News:
(Date:11/26/2014)... , Nov. 25, 2014  goBalto, Inc., the ... been recognized as a winner of Red Herring,s ... Global Top 100 North America award in 2013, marking ... technology landscape. Red Herring,s Top 100 Global ... promising new companies and entrepreneurs. Red Herring editors were ...
(Date:11/26/2014)... 25, 2014   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will attend The Benchmark Company, LLC,s Micro Cap ... will be held at The Palmer House Hilton, 17 E. ... a.m. to 2:30 p.m. Please email hska@haydenir.com or ...
(Date:11/26/2014)... and LONDON , Nov. 25, 2014 /PRNewswire/ ... AZN ) today announced that AMAGINE-2 TM , ... brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis, ... (ustekinumab) and placebo at week 12. Brodalumab 210 mg ... were each shown to be superior to Stelara on the ...
Breaking Medicine Technology:goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... Safety and Efficacy Data Presented at 1st IASLC-ESMO European Lung ... ... 23 Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company ... 2,clinical trial of picoplatin confirming previously announced interim,results showing a survival ...
... 23 Archus Orthopedics, Inc.,announced today that it ... TFAS-C(TM) system, the newest addition to the company,s ... which degenerative changes in,the facet joints result in ... legs. Traditionally, patients with moderate to,severe spinal stenosis ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit 2Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit 3Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit 4First Human Implant of New Archus Orthopedics Facet Replacement System 2
... highest g-force ever. But optimal productivity in ... MAX combines maximum force, capacity, and ease ... worlds apart from any other system. With ... efficiency, Optima takes productivity to the MAX. ...
... ultracentrifuge is designed to play a ... if research involves proteomics, cytomics or ... computer, enhanced firmware, powerful Optima eXPert ... Optima L-XP delivers superior functionality, optimized ...
... The Dimension Xpand integrated chemistry ... compact footprint to the smaller laboratory. ... The Dimension Xpand integrated chemistry system ... tailored for the low-volume environment, in ...
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
Medicine Products: